Brent Sabatini insider trades: Vir Biotechnology (VIR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brent reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | VIR | ↓ Sell | 379 | $9.45 | $4K | Direct | Jun 2, 2026 (1d) |
| Mar 23, 2026 | VIR | ↓ Sell | 7,711 | $9.12 | $70K | Direct | Mar 24, 2026 (1d) |
| Feb 23, 2026 | VIR | ↓ Sell | 1,829 | $7.45 | $14K | Direct | Feb 24, 2026 (1d) |
| Feb 13, 2026 | VIR | ↓ Sell | 1,530 | $7.79 | $12K | Direct | Feb 18, 2026 (5d) |
| Feb 24, 2025 | VIR | ↓ Sell | 1,562 | $9.45 | $15K | Direct | Feb 25, 2025 (1d) |
| Feb 13, 2025 | VIR | ↓ Sell | 1,562 | $9.15 | $14K | Direct | Feb 14, 2025 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VIR insiders
Open-market trades in the last 12 months
About Brent Sabatini's insider trades
Brent Sabatini is SVP, Chief Accounting Officer at Vir Biotechnology (VIR). Since Feb 13, 2025, Brent has reported no open-market purchases and 6 sales worth $129K on SEC Form 4. In the last 12 months: 4 sales ($99K).
Their filings also include grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VIR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.